Merck & Ridgeback’s Molnupiravir Receives Special Emergency Approval in Japan
Global pharmaceutical major Merck & Co., Inc. (NYSE:MRK) recently revealed that its investigational, orally administered antiviral medicine for treatment of COVID-19, molnupiravir, has been gra...